TTrialPathMatch Me to Trials
← Back to trials
RecruitingProstate Cancer

Understanding of Genetics by Men at Risk for Prostate Cancer

Eligible age

40–95 yrs

Accepts

Men

Locations

3 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

With this greater certainty regarding prognosis, men with localized prostate cancer are now equipped with make better treatment planning decisions. This study is designed to investigate the understanding of prognostic genetic technology in African American and rural White men at risk for localized prostate cancer.

Sponsor: Mayo Clinic

You may qualify if…

  • ✓ African-American or White men
  • ✓ Living in a rural or urban areas
  • ✓ Age 40 to 95 years old
  • ✓ Able and willing to provide informed consent
  • ✓ English-speaking
  • ✓ Willing to participate in the study.
  • ✓ This study will use the United States Department of Agriculture Office of Rural Development's definition of rural, which is as a city or town that has a population less than 50,000 inhabitants to define rural.
  • ✓ This study will use the United States Census Bureau's definition of urban, which is a city or town that has a population greater than 50,000 inhabitants to define urban.

You may not qualify if…

  • ✕ Women will be excluded from participating in this study. However, women will be recruited to serve on an advisory panel to review the video-based educational tool for the comprehension of genomic terminology for prognostic genetic testing in patients with localized prostate cancer.

Where it's recruiting

Arizona

Phoenix

Florida

Jacksonville

Minnesota

Rochester

Source: ClinicalTrials.gov · NCT04550845 · last updated 2025-11-06